Skip to main content

Alfons Macaya Ruíz

Institutions of which they are part

Main researcher
Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases
Vall Hebron Institut de Recerca

Alfons Macaya Ruíz

Institutions of which they are part

Main researcher
Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases
Vall Hebron Institut de Recerca

Projects

Enfermedades minoritarias causantes de degeneración de ganglios basales en pedriatría: implemementación combinada del análisis genómico y de biomarcadores.

IP: Belen Perez Dueñas
Collaborators: José Antonio Arranz Amo, Josefa Élida Vázquez Méndez, Alfons Macaya Ruíz, Anna Marcé Grau, Clara Carnicer Cáceres, Mireia Del Toro Riera, Ana Felipe Rucián, Amaia Lasa Aranzasti
Funding agency: Instituto de Salud Carlos III
Funding: 196020
Reference: PI18/01319
Duration: 01/01/2019 - 31/12/2022

Grups de recerca en Neurologia Pediatrica

IP: Alfons Macaya Ruíz
Collaborators: David Gómez Andrés
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2017SGR01710
Duration: 01/01/2017 - 31/12/2020

Implementació de la Medicina Personalitzada basada en la Genòmica en Malalties Minoritàries Neurològiques no Diagnosticades

IP: Alfons Macaya Ruíz
Collaborators: Elena García Arumí, Francina Munell Casadesus, Teresa Vendrell Bayona, Ramon Martí Seves, David Gómez Andrés
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 113977.67
Reference: SLT002/16/00174
Duration: 01/01/2017 - 31/12/2019

Exoma diagnóstico, exoma de investigación y genoma completo: maximizando el rendimiento de la secuenciación masiva en las encefalopatís epilépticas precoces

IP: Alfons Macaya Ruíz
Collaborators: Anna Marcé Grau, Miquel Raspall Chaure
Funding agency: Instituto de Salud Carlos III
Funding: 140965
Reference: PI15/01791
Duration: 01/01/2016 - 30/11/2020

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Over the course of one week, it will host in-person assessments for 35 families to better understand the progression of the disease and contribute to the development of new therapies.

The event focused on advances in disease-modifying therapies and on the value of alliances between patients and professionals to promote more participatory care and research.

Related professionals

Jordi Morillas Ros

Jordi Morillas Ros

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more
David Campany Herrero

David Campany Herrero

Predoctoral researcher
Basic, Translational and Clinical Pharmacy Research
Read more
Lorena Tamborero Martin

Lorena Tamborero Martin

Research assistant
Multidisciplinary Nursing Research Group
Read more
Aroha Domínguez Soto

Aroha Domínguez Soto

Fundraising Unit
Communication Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.